Vanda Pharmaceuticals (VNDA) Cost of Revenue (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Cost of Revenue of $3.56 million for Q2 2026, up 30.1% from $2.74 million a year earlier and up 12.7% from the prior quarter.
Vanda Pharmaceuticals (VNDA) Cost of Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vanda Pharmaceuticals' Cost of Revenue came in at $13.51 million, up 18.5% year-over-year; for FY2025, it was $13.04 million, up 15.3% from FY2024.
- Cost of Revenue has a five-year compound annual growth rate of -11.0% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $11.31 million in FY2024 (-23.5%), $14.8 million in FY2023 (-39.1%), $24.28 million in FY2022 (-5.3%) and $25.63 million in FY2021 (+9.7%).
- Five-year quarterly Cost of Revenue spans a low of $2.55 million in Q3 2024 and a high of $6.8 million in Q3 2021.
- Year over year, Cost of Revenue gained in five of the last eight quarters, with growth averaging 5.5%.
- The high point for year-over-year Cost of Revenue in five years was Q4 2025 (growth of 48.0%); the low point was Q3 2023 (a decline of 51.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.16 million (Q1 2026), $3.83 million (Q4 2025) and $2.95 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | 3.56 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.56 Mn |
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 2.95 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 6.24 Mn |
| Sep 30, 2022 | 6.32 Mn |
| Jun 30, 2022 | 6.06 Mn |
| Mar 31, 2022 | 5.67 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Sep 30, 2021 | 6.80 Mn |
Vanda Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();